Sickle Cell Disease in Childhood From Newborn Screening Through Transition to Adult Medical Care

被引：66
|
作者：
Quinn, Charles T. [1 ,2 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45229 USA
来源：
PEDIATRIC CLINICS OF NORTH AMERICA | 2013年 / 60卷 / 06期
关键词：
Sickle cell disease; Genetics; Diagnosis; Pathophysiology; Treatment; Survival; ACUTE CHEST SYNDROME; PULMONARY-HYPERTENSION; ADVERSE OUTCOMES; CHILDREN; ANEMIA; STROKE; TRANSFUSIONS; HOSPITALIZATION; DEXAMETHASONE; HYDROXYUREA;
D O I：
10.1016/j.pcl.2013.09.006
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Sickle cell disease (SOD) is the name for a group of related blood disorders caused by an abnormal hemoglobin molecule that polymerizes on deoxygenation. SOD affects the entire body, and the multisystem pathophysiology begins in infancy. Thanks to prognostic and therapeutic advancements, some forms of SOD-related morbidity are decreasing, such as overt stroke. Almost all children born with SOD in developed nations now live to adulthood, and lifelong multidisciplinary care is necessary. This article provides a broad overview of SOD in childhood, from newborn screening through transition to adult medical care.
引用
收藏
页码：1363 / +
页数：20
相关论文
共 50 条
  • [1] Transition from paediatric to adult care for patients with sickle cell disease
    de Montalembert, Mariane
    Guitton, Corinne
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (05) : 630 - 635
  • [2] Management of sickle cell disease from childhood through adulthood
    Kanter, Julie
    Kruse-Jarres, Rebecca
    BLOOD REVIEWS, 2013, 27 (06) : 279 - 287
  • [3] Mortality of New York children with sickle cell disease identified through newborn screening
    Wang, Ying
    Liu, Gang
    Caggana, Michele
    Kennedy, Joseph
    Zimmerman, Regina
    Oyeku, Suzette O.
    Werner, Ellen M.
    Grant, Althea M.
    Green, Nancy S.
    Grosse, Scott D.
    GENETICS IN MEDICINE, 2015, 17 (06) : 452 - 459
  • [4] Newborn Screening for Sickle Cell Disease and Thalassemia
    Quarmyne, Maa-Ohui
    Bock, Fiona
    Lakshmanan, Sangeetha
    Attell, Brandon K.
    Snyder, Angela
    Boudreaux, Jeanne
    Sheth, Sujit
    Bender, M. A.
    Lal, Ashutosh
    JAMA HEALTH FORUM, 2025, 6 (03):
  • [5] A Novel Newborn Screening Program for Sickle Cell Disease in Nigeria
    Galadanci, Aisha A.
    Ibrahim, Umma A.
    Carroll, Yvonne
    Jobbi, Yusuf D.
    Farouk, Zubaida L.
    Mukaddas, Aisha
    Hussaini, Nafiu
    Sani Musa, Bilya
    Klein, Lauren J.
    Debaun, Michael R.
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2024, 10 (04)
  • [6] Complications of sickle cell disease, from childhood to adulthood
    de Montalembert, Mariane
    Pinhas, Yael
    Brice, Josephine
    Taylor, Melissa
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2024, 208 (05): : 642 - 647
  • [7] Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain
    Castilla-Rodriguez, Ivan
    Cela, Elena
    Vallejo-Torres, Laura
    Valcarcel-Nazco, Cristina
    Dulin, Elena
    Espada, Mercedes
    Rausell, Dolores
    Mar, Javier
    Serrano-Aguilar, Pedro
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (06): : 567 - 575
  • [8] Newborn screening for sickle cell disease: necessary but not sufficient
    Wang, Winfred C.
    JORNAL DE PEDIATRIA, 2015, 91 (03) : 210 - 212
  • [9] Newborn Screening for Sickle Cell Disease: Jamaican Experience
    Mason, K.
    Gibson, F.
    Gardner, R.
    Warren, L.
    Fisher, C.
    Higgs, D.
    Happich, M.
    Kulozik, A.
    Hambleton, I.
    Serjeant, B. E.
    Serjeant, G. R.
    WEST INDIAN MEDICAL JOURNAL, 2016, 65 (01) : 18 - 26
  • [10] A Biopsychosocial Model for the Management of Patients With Sickle-Cell Disease Transitioning to Adult Medical Care
    Crosby, Lori E.
    Quinn, Charles T.
    Kalinyak, Karen A.
    ADVANCES IN THERAPY, 2015, 32 (04) : 293 - 305
12345